Physician profile

Steven M Pesenko

Podiatrist · Chicago, IL

NPI 1962506378

$249.57

in general payments reported to CMS, 2019-2025

9 companies · none reported in 2025

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$162.37

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Smith+Nephew, INC. $122.28 2023 Grafix
Orthofix Medical, INC. $26.84 2023 Physio-Stim
Melinta Therapeutics, LLC $19.57 2022
Grt US Holding, INC. $17.31 2022
Tactile Systems Technology INC $13.76 2020
Next Science LLC $13.25 2023 Surgx, Blastx, Xperience
Organogenesis INC. $12.97 2022
Bioventus LLC $12.44 2020
Zimmer Biomet Holdings, INC. $11.15 2021

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Steven M Pesenko

$249.57

in general payments reported 2019-2025

Years
2020-2023
Top company
Smith+Nephew, INC.

https://glasscript.com/doctor/88468/steven-m-pesenko

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.